Our blogs aim to share thought leadership on digital transformation of Bio-Pharmaceutical supply chain. We invite unique perspectives, tips and advice to drive change, foster intellectual growth and development.
A recent spotlight by The Wall Street Journal on the inadequate diversity in clinical studies underscores a pivotal issue in healthcare research – the urgent need for broader participant demographics to ensure the completeness and applicability of medical data.(https://www.wsj.com/health/healthcare/medical-studies-too-white-14e60b22).
This movement towards inclusivity is not just a nod to ethical research practices but a critical step towards enhancing the validity of clinical trials across varied populations.
